Viewing Study NCT04156256


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2025-12-25 @ 9:19 PM
Study NCT ID: NCT04156256
Status: UNKNOWN
Last Update Posted: 2019-11-12
First Post: 2019-11-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies
Sponsor: iCell Gene Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module